FAMOTIN TABLET 20 mg Singapore - English - HSA (Health Sciences Authority)

famotin tablet 20 mg

teva pharmaceutical investments singapore pte. ltd. - famotidine - tablet - 20 mg - famotidine 20 mg

FAMOTIN TABLET 40 mg Singapore - English - HSA (Health Sciences Authority)

famotin tablet 40 mg

teva pharmaceutical investments singapore pte. ltd. - famotidine - tablet - 40 mg - famotidine 40 mg

FAMOTIDINE tablet United States - English - NLM (National Library of Medicine)

famotidine tablet

bluepoint laboratories - famotidine (unii: 5qzo15j2z8) (famotidine - unii:5qzo15j2z8) - famotidine tablets are indicated in adult and pediatric patients 40 kg and above for the treatment of: - active duodenal ulcer (du). - active gastric ulcer (gu). - symptomatic nonerosive gastroesophageal reflux disease (gerd). - erosive esophagitis due to gerd, diagnosed by biopsy. famotidine tablets are indicated in adults for the: - treatment of pathological hypersecretory conditions (e.g., zollinger-ellison syndrome, multiple endocrine neoplasias). - reduction of the risk of duodenal ulcer recurrence. famotidine tablets are contraindicated in patients with a history of serious hypersensitivity reactions (e.g., anaphylaxis) to famotidine or other histamine-2 (h 2 ) receptor antagonists. risk summary available data with h 2 -receptor antagonists, including famotine, in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. in animal reproduction studies, no adverse development effects were observ